Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Nordic Nanovector ASA Thor Medical As - M&A Call Transcript

Jun 07, 2023 / 08:00AM GMT
Release Date Price: kr1.58 (+64.75%)
Ludvik Sandnes
Nordic Nanovector ASA - Interim CEO & CFO

(foreign language) And good morning, all. It's a great pleasure and [some pride] that I today can present the deal initiated by our founder, Roy Larsen, and another [serial] entrepreneur Norway, Alf Bjorseth.

They will both address you after a short introduction of what we have agreed. And we'll propose to you at our AGM to be sent to you today, and it will be held on the 28th of June. We have already 30% previous consent, so we really hope that we will also have this deal accepted.

The deal has been negotiated with great support also from our major shareholder in North Energy, who has been an insider since third of March, 3 months, and has attended the meetings with Thor Medical.

The -- mind you, we have agreed to acquire Thor Medical's highly promising new technology that enables the development and production of radionuclides for radio immunoconjugate-based approaches to cancer treatment, a rapidly growing global market. We continue to be a cancer-fighting company, that's very important for us.

We also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot